Drug Pipeline

Sonidegib Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
1
Recruiting
3
Top Sponsors
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-05 NCT05669339
AD HOC Trial: Artificial Intelligence-Based Drug Dosing In Hepatocellular Carcinoma		 date change Primary completion pushed: 2026-04 -> 2027-04
2026-06-05 NCT05669339
AD HOC Trial: Artificial Intelligence-Based Drug Dosing In Hepatocellular Carcinoma		 date change Completion pushed: 2026-04 -> 2027-04
Active Studies by Phase
Phase 2
2
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT05669339 AD HOC Trial: Artificial Intelligence-Based Drug Dosing In Hepatocellular Carcinoma Hepatocellular Carcinoma Recruiting
NCT04806646 Tailored Sonidegib Schedule After Complete Response in BCC Locally Advanced Basal Cell Carcinoma Active, Not Recruiting
Phase 1
NCT04007744 Sonidegib and Pembrolizumab in Treating Patients With Advanced Solid Tumors Clinical Stage III Cutaneous Melanoma AJCC v8 Active, Not Recruiting
Sponsors Running Sonidegib Trials
Mayo Clinic (1) Gruppo Oncologico del Nord-Ovest (1) University of Florida (1)
Disease Areas
Non-Small Cell Lung Cancer (NSCLC) (1) Lung Cancer (1) Gastric Cancer (1) Bladder Cancer (1) Melanoma (1) Head & Neck Cancer (1) Liver Cancer (1)
Get alerts when Sonidegib trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free